The board of directors of the company on September 24, will consider a proposal for buy-back of equity shares upto such amount of the aggregate of company's paid up equity share capital and free reserves.
JBF Industries purchased its 3,99,800 shares or 0.55 percent of total paid up equity at Rs 91.59 apiece, which is a part of buyback offer that opened on September 4.
JSPL Board had approved the buyback offer on August 30 and fixed a price of Rs 261 per share for the offer to be conducted through stock exchanges.
Jindal Steel & Power approved the buy-back of equity shares from its existing shareholders (other than promoters, promoter group, persons in control and persons acting in concert), at a price not exceeding Rs 261 per equity share
The board of directors of JBF Industries approved buy-back of equity shares from the existing equity shareholders other than promoters and the persons who are in control of the company.
Bayer Cropscience approved a buyback proposal for purchase by the company of upto 28,79,746 equity shares of Rs 10 each (representing 7.29 percent of the total equity capital), from all the shareholders on a proportionate basis through the tender offer at a price of Rs 1,580 per share, aggregating to approximately Rs 455 crore.
Piramal Healthcare buyback offer has opened today and will close on March 24, reports CNBC-TV18. It touched an intraday high of Rs 469.75 and an intraday low of Rs 458. At 12:58 hrs the share was quoting at Rs 466, up Rs 6.70, or 1.46%.